This Article  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

William R. Barclay, MD

JAMA. 1978;240(4):377-378.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Important findings of medical research, especially those supported by general tax revenues, should be made known to the public as well as to the medical profession. However, both the public and the profession are entitled to an accurate account, and any speculation that goes beyond what can be firmly supported by the data should be curtailed.

An article by the University Group Diabetes Program (UGDP) in the July 7, 1978, issue of THE JOURNAL and a news story based on that article in the Wall Street Journal on July 5 have reopened a bitter controversy that could be harmful to patients and physicians if not placed in a proper perspective. The article in THE JOURNAL compares macrovascular complications in adult-onset, non-insulin-dependent diabetics who were divided into three groups: one received a placebo, one a fixed dose of insulin, and one a variable dose of insulin that was adjusted to keep . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?